The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Reversal of Oncogenesis by the Expression of a Major Histocompatibility Complex Class I Gene
Abstract
The classical transplantation antigens (the major histocompatibility complex class I antigens) play a key role in host defense against cells expressing foreign antigens. Several naturally occurring tumors and virally transformed cells show an overall suppression of these surface antigens. Since the class I molecules are required in the presentation of neoantigens on tumor cells to the cytotoxic T lymphocytes, their absence from the cell surface may lead to the escape of these tumors from immunosurveillance. To test this possibility, a functional class I gene was transfected into human adenovirus 12-transformed mouse cells that do not express detectable levels of class I antigens; the transformants were tested for expression of the transfected gene and for changes in oncogenicity. The expression of a single class I gene, introduced by DNA-mediated gene transfer into highly tumorigenic adenovirus 12-transformed cells, was sufficient to abrogate the oncogenicity of these cells. This finding has important implications for the regulation of the malignant phenotype in certain tumors and for the potential modulation of oncogenicity through derepression of the endogenous class I genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Southern, P. J., & Berg, P. R. (1982) · PubMed · Cited by 2,740
Zinkernagel, R. M., & Doherty, P. C. (1979) · Advances in Immunology · doi:10.1016/s0065-2776(08)60262-x · Cited by 1,933
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I., & Howard, B. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6777 · Cited by 1,298
Schrier, P. I., Bernards, R., Vaessen, R. T. M. J., Houweling, A., & van der Eb, A. J. (1983) · Nature · doi:10.1038/305771a0 · Cited by 559
Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation
Hui, K., Grosveld, F., & Festenstein, H. (1984) · Nature · doi:10.1038/311750a0 · Cited by 341
Parnes, J. R., Velan, B., Felsenfeld, A., Ramanathan, L., Ferrini, U., Appella, E., & Seidman, J. G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2253 · Cited by 314
Mouse Teratocarcinoma and Embryonic Antigens
Jacob, F. (1977) · Immunological Reviews · doi:10.1111/j.1600-065x.1977.tb00360.x · Cited by 268
Fellous, M., Nir, U., Wallach, D., Merlin, G., Rubinstein, M., & Revel, M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3082 · Cited by 261
Arce‐Gomez, B., Jones, E. A., Barnstable, C. J., Solomon, E., & Bodmer, W. F. (1978) · Tissue Antigens · doi:10.1111/j.1399-0039.1978.tb01233.x · Cited by 221
Enhancement by Interferon of the Expression of Surface Antigens on Murine Leukemia L 1210 Cells
Lindahl, P., Leary, P., & Gresser, I. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.10.2785 · Cited by 200
Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.
Lindahl, P., Gresser, I., Leary, P., & Tovey, M. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.4.1284 · Cited by 163
Characterization of cells transformed by Ad5/Ad12 hybrid early region I plasmids
Bernards, R., Houweling, A., Schrier, P. I., Bos, J. L., & van der Eb, A. J. (1982) · Virology · doi:10.1016/0042-6822(82)90042-3 · Cited by 112
Developmental activation of the H-2K gene is correlated with an increase in DNA methylation
Tanaka, K., Appella, E., & Jay, G. (1983) · Cell · doi:10.1016/0092-8674(83)90179-4 · Cited by 105
Self-citationTissue-specific expression of an unusual H-2 (class I)-related gene.
Cosman, D. J., Kress, M., Khoury, G., & Jay, G. D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.16.4947 · Cited by 96
Self-citationThe relationship between in vitro transformation and tumor formation in vivo
Pontén, J. (1976) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(76)90009-3 · Cited by 90
Functional Insertion of an Alu Type 2 (B2 SINE) Repetitive Sequence in Murine Class I Genes
Kress, M., Barra, Y., Seidman, J. G., Khoury, G., & Jay, G. (1984) · Science · doi:10.1126/science.6095445 · Cited by 67
Self-citationAlternative RNA splicing in expression of the H–2Kgene
Kress, M., Glaros, D. S., Khoury, G., & Jay, G. (1983) · Nature · doi:10.1038/306602a0 · Cited by 65
Self-citationYamamoto, T. S., Jay, G. D., & Pastan, I. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.176 · Cited by 65
Self-citation
Cited by
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Chen, L., Ashe, S., Brady, W. A., Hellström, I., Hellström, K. E., Ledbetter, J. A., McGowan, P., & Linsley, P. S. (1992) · Cell · doi:10.1016/s0092-8674(05)80059-5 · Cited by 1,050
Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B., & Frost, P. (1990) · Cell · doi:10.1016/0092-8674(90)90591-2 · Cited by 916
Ljunggren, H. G., & Kärre, K. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.1745 · Cited by 736
Metadata
- Authors
- Tanaka, K., Isselbacher, K. J., Khoury, G., & Jay, G.
- Venue
- Science
- Published
- 1985-04-05
- Volume
- 228
- Issue
- 4695
- Pages
- 26-30
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029793114
- Cited by
- 366
- References
- 19
- FWCI
- 15.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.